JP Morgan Downgrades Treace Medical Concepts to Underweight, Lowers Price Target to $5
Benzinga Newsdesk 12 months ago
NewsDowngradesPrice TargetAnalyst Ratings
JP Morgan analyst Lilia-Celine Lozada downgrades Treace Medical Concepts (NASDAQ:TMCI) from Neutral to Underweight and lowers the price target from $8 to $5.
JP Morgan analyst Lilia-Celine Lozada downgrades Treace Medical Concepts (NASDAQ:TMCI) from Neutral to Underweight and lowers the price target from $8 to $5.